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Chau, Connie, Hugues Barbeau, and Serge Rossignol. Effects review, see . For example, in in vitro neonaof intrathecal a 1 -and a 2 -noradrenergic agonists and norepinephrine tal rat preparation, locomotor activity have been found to be on locomotion in chronic spinal cats. J. Neurophysiol. 79: 2941-released by EAA (Cazalets et al. 1990 ; Kudo and Yamada 2963, 1998 . Noradrenergic drugs, acting on a adrenoceptors, have Smith and Feldman 1987) , serotonin (Cazalets et al. been found to play an important role in the initiation and modula-1992; Cowley and Schmidt 1994; Kiehn and Kjaerulff tion of locomotor pattern in adult cats after spinal cord transection. 1996) , and cholinergic drugs (Katakura and Chandler There are at least two subtypes of a adrenoceptors, a 1 and a 2 1991). In chronic spinal cats, among the different pharmacoadrenoceptors. The aim of this study was to investigate the effects logical agents, noradrenergic drugs were found to be the of selective a 1 and a 2 agonists in the initiation and modulation of locomotion in adult chronic cats in the early and late stages after most effective in initiating locomotion (Barbeau and Rossigcomplete transection at T 13 . Five cats, chronically implanted with nol 1991; . The importance of the noradan intrathecal cannula and electromyographic (EMG) electrodes renergic system has been shown by early studies from were used in this study. Noradrenergic drugs including a 2 agonists Lundberg and colleagues (Anden et al. 1966a,b; Jankowska (clonidine, tizanidine, and oxymetazoline) and an antagonist, yo-et al. 1967 ) who demonstrated the ability of noradrenergic himbine, one a 1 agonist (methoxamine), and a blocker, prazosin, agents to activate neuronal circuits that could be responsible as well as norepinephrine were injected intrathecally. EMG activity for locomotor function. They showed that intravenous injecsynchronized to video images of the hindlimbs were recorded betion of the noradrenergic precursor, dihydroxy phenylalanine fore and after each drug injection. The results show differential effects of a 1 and a 2 agonists in the initiation of locomotion in early (DOPA) inhibited the transmission of short latency respinal cats (i.e., in the first week or so when there is no spontaneous sponses from the flexor reflex afferent (FRA) but released locomotion) and in the modulation of locomotion and cutaneous long-latency and long-duration discharges not normally reflexes in the late-spinal cats (i.e., when cats have recovered spon-found in acute spinal cats. These late discharges often taneous locomotion). In early spinal cats, all three a 2 agonists evolved as sequences of rhythmically alternating activity were found to initiate locomotion, although their action had a dif-between flexors and extensors reminiscent of stepping. It ferent time course. The a 1 agonist methoxamine induced bouts of was suggested indeed that the interneuronal circuitry genernice locomotor activity in three spinal cats some hours after injecating the late discharges evoked after DOPA could be retion but only induced sustained locomotion in one cat in which sponsible for generating locomotion. This was pursued by the effects were blocked by the a 1 antagonist prazosin. In late spinal cats, although a 2 agonists markedly increased the cycle dura- Grillner and Zangger (1979) who showed that a detailed tion and flexor muscle burst duration and decreased the weight locomotor rhythm can be generated by the neuronal circuitry support or extensor activity (effects blocked by an a 2 antagonist, within the spinal cord itself. Indeed, after the injection of yohimbine), a 1 agonist increased the weight support and primarily the noradrenergic precursor (DOPA) and nialamide (a the extensor activity of the hindlimbs without markedly changing monoamine oxidase inhibitor), a pattern of rhythmic alterthe timing of the step cycle. Although a 2 agonists, especially cloni-nating discharges in antagonist hindlimb muscle nerves was dine, markedly reduced the cutaneous excitability and augmented observed in acute spinal and curarized cat. DOPA (intravethe foot drag, the a 1 agonist was found to increase the cutaneous nously) has been postulated to mediate its effects through the reflex excitability. This is in line with previously reported differential effects of activation of the two receptors on motoneuron excit-activation of noradrenergic receptors (Anden et al. 1966a,b) . ability and reflex transmission. Noradrenaline, the neurotransmitter Using a noradrenergic receptor agonist (clonidine), Forssitself, increased the cycle duration and at the same time retained berg and Grillner (1973) demonstrated the ability of noradthe cutaneous excitability, thus exerting both a 1 and a 2 effects. renergic drugs to initiate locomotion. They showed in acute This work therefore suggests that different subclasses of noradren-spinal cats (Th12) that after an intravenous injection of clonergic drugs could be used to more specifically target aspects of idine, cats could walk with both hindlimbs when placed on locomotor deficits in patients after spinal injury or diseases. a moving treadmill belt. They suggested that the descending noradrenergic system could ''release'' the spinal circuitry for stepping. These results were supported by work in our I N T R O D U C T I O N laboratory confirming that clonidine (intraperitoneally) can trigger hindlimb treadmill locomotion in adult chronic spinal Different neurotransmitters such as norepinephrine, serocats (awake behaving animal) within the first week after tonin, excitatory amino acids (EAA), and acetylcholine, spinalization . In a recent paper (Chau have been identified to play a role in the initiation and modulation of locomotion in different animal preparations (for et al. 1998) , we reported the effects of early locomotor training with daily injection of clonidine (intraperitoneally A more detailed understanding of the noradrenergic drugs, and their actions mediated by different receptors, is imin 4 cats, and intrathecally in 1 cat) within the first week after spinal transection. In the present work, we have pursued portant to enhance our ability to optimize the therapeutic use of drugs in patients with spinal cord injury and potenthese ideas with the aim of better identifying the potential of various noradrenergic drugs, in addition to clonidine, act-tially better target the pharmacotherapy to offset more specific locomotor deficits. ing on different receptors to initiate and modulate locomotion.
In contrast to our previous work where drugs were injected M E T H O D S intraperitoneally, the present study used an intrathecal canFive adult cats were used for this study. They were trained to nula exclusively for drug delivery. This not only reduced walk on a motor driven treadmill belt and could walk continuously some side effects encountered with intraperitoneal injections for ¢15 min at 0.3-0.4 m/s. After training, they were chronically but also greatly expanded our ability to explore a wider implanted with electromyographic (EMG) electrodes and an invariety of drugs. Because the drugs were injected directly trathecal catheter. In two cats, nerve cuffs electrodes also were into the intrathecal space of the spinal cord, central effects chronically implanted on the superficial peroneal nerve. Once baseline recordings of the intact locomotion were made, cats were of the drugs dominated over peripheral effects. It also made spinalized. possible testing drugs that do not cross the blood brain barAll surgeries were performed in aseptic conditions. Cats were rier, such as oxymetazoline and thus explore various types anesthetized with intravenous pentobarbital (Somnotol, 35 mg/ of a 2 agonists. Thus adult spinal cats implanted with an kg). Additional doses of barbiturates (3-5 mg/kg iv) were given intrathecal cannula may serve as a unique model where the as needed throughout the surgery to ensure that the animal reeffects of different pharmacological agents on locomotion mained deeply anesthetized. Lactate-Ringer solution was given can be studied.
continuously through an intravenous line during surgery. The body Although the importance of noradrenergic system in in-temperature was constantly monitored with a rectal thermometer ducing and modulating locomotion in spinal animal was es-and controlled by placing the cat on a heating pad. All procedures tablished, relatively little information is available on the followed a protocol approved by the Ethics Committee of Uni- ceptors have been shown in previous studies using DOPA The tip of the catheter was perforated with a few holes on the side or clonidine to be involved in triggering locomotion and to ensure drug infusion. Before insertion, the catheter was filled thus would be the focus of this paper.
with sterile saline, and the dead space of the catheter was measured
The a noradrenergic receptors are subdivided broadly into (Ç100 ml). With the cats's head secured in the stereotaxic frame, the a 1 and a 2 subtypes. The two subtypes of noradrenergic a midline incision was made from the cranium to C 2 -C 3 level. receptors have been reported to mediate different functions. One end of the catheter was secured on the skull with acrylic For example, it was found that activation of a 1 receptors cement as a port of entry while the other end was inserted through facilitate the flexor reflex whereas activation of a 2 receptors an opening in the cisterna magna down to approximately L 4 -L 5 appears to mediate inhibitory effects in acutely spinalized (Fig. 1) . In one spinal cat (CC4), X-rays were taken at different times after the injection of an radio opaque dye into the cannula rats (Sakitama 1993). Clonidine acts primarily on the a 2 -and showed that the tip of the cannula was located at L 5 and that adrenergic receptor (Marshall 1983; Ruffolo and Hieble the diffusion of the radio opaque material was localized within the 1994; Timmermans and van Zwieten 1982) . It was shown lumbosacral region. that clonidine could stimulate central norepinephrine recepAfter the catheterization, the cannula was flushed daily with 100 tors in acute spinal rats, suggesting the role of a a 2 receptor ml sterile saline to prevent blocking. The location of the tip of the (Anden et al. 1970) . So far, clonidine remained the norad-catheter was identified during postmortem examination and is listed renergic agonist most widely used to induce, ameliorate and for all cats in Table 1 . Postmortem examination also revealed that modulate locomotion in acute or chronic spinalized cats the cannula can leave an imprint on the cord. This compression Forssberg and Grillner 1973;  did not, however, produce any apparent locomotor deficits in our . Little is known about the effects cats because they all walked well after the implantation. of other a 2 -adrenergic receptors or effects mediated by a 1 IMPLANTATION OF EMG ELECTRODES. A detailed description adrenoceptors.
has been made elsewhere (Chau et al. 1998) . Briefly, three cats
The purpose of this study was to explore the functional were implanted with two 15-pin head connectors (TRW Electronic Components Group) while two cats were implanted with only one role of a 1 and a 2 adrenoceptors in the initiation and modulaconnector secured to the cranium using acrylic cement. Seven or tion of locomotion and cutaneous reflexes after spinal cord 14 pairs of the Teflon-insulated stainless steel wires (previously transection in chronic spinal cats. As spinalization removed soldered to the head connectors) were passed subcutaneously to all presynaptic receptors by removing all descending noradsmall incisions made overlying the selected hindlimb muscles (Fig. renergic terminals, the receptors activated are presumed to be 1). A pair of stainless steel wires was sewn into the belly of each located postsynaptically. To compare with clonidine, other muscle. Before insertion, a small portion of the Teflon coating selective a 2 agonists, tizanidine and oxymetazoline were was removed from the Teflon-insulated stainless steel wires to be used, and yohimbine was injected in some cases to antago-inserted in the muscle. Unpaired wires from the last pin of each nize their effects. Methoxamine, a selective a 1 -adrenoceptor connector were placed under the skin of the neck to serve as an agonist (Marks et al. 1990 ) and prazosin, a selective blocker electrical ground. Bilaterally implanted muscles include iliopsoas FIG . 1. Scheme showing the experimental set-up during locomotion. Hindlimbs of the cat were placed on the moving treadmill belt while the forelimbs stood on a stationary platform (É2 cm above). Both the head connector and the cannula inlet port are fixed on the head as shown. Details of the recording procedures and synchronization procedures are described in METH-ODS . Four joint angles are measured so that flexion will result in a decrease of angular values. MTP, metatarso-phalangeal joint.
semitendinosus (St), a knee flexor and hip extensor; vastus later-level of transection area. The exact location of the intrathecal cannula first was identified to avoid causing any damage to the cannula, alis (VL), a knee extensor; gastrocnemius lateralis (GL), an ankle extensor and knee flexor; and tibialis anterior (TA), an ankle then the spinal cord was completely severed progressively using microscissors. The spinal canal could be visualized clearly, and an flexor. Electrodes also were inserted unilaterally into gluteus medius (Glu), a hip abductor and extensor, and in gastrocnemius absorbable hemostat (Surgicel, oxidized regenerated cellulose) was used to fill the space between the rostral and caudal ends of medialis (GM), an ankle extensor and knee flexor.
the spinal cord. The completeness of the spinal transection was IMPLANTATION OF NERVE CUFF ELECTRODES. In two cats later confirmed with histological analysis (10-mm sections using (CC5 and CC7), bipolar cuff electrodes (Julien and Rossignol the Kluver-Barrera method). 1982) (Ç1 cm length) were used to stimulate the superficial peroneal nerve (Ç6 mm between electrodes leads). A 2-pin head connector, soldered with a pair of Teflon-insulated stainless steel wires Postoperative cares was used. The stainless steel wires were led to the site of implantation subcutaneously. Using a custom-made apparatus, a U-shaped All animals were placed in an incubator immediately after surnerve cuff was made from polymer (Caulk Dentsply International). gery and monitored closely. Once the animals regained consciousThe wires were anchored to the nerve cuff and the small portion ness, they were placed in individual cages (104 1 76 1 94 cm) of stainless steel wires inside the cuff was cleared of the Teflon with food and water. Torbugesic (Butorphenol tartrate, 0.05 mg insulation. The superficial peroneal nerve was placed in the cuff sc, every 6 h) was given in the first postoperative day to reduce followed by absorbable gelatin sponge (Sterispon) soaked with discomfort. Spinal cats were placed in cages lined with foam matsaline solution to prevent damages related to secondary swelling tresses and were attended to a few times daily to maintain the and was completely sealed off using polymer.
cleanliness of the head connectors, to flush the intrathecal cannula with sterile saline, to express the bladder manually, and to inspect SPINALIZATION. A laminectomy was performed at the T 13 vertebra. The dura was carefully removed, a few drops of xylocaine and clean the hindquarters. All our spinal cats remained very healthy and were kept for a period of 2-9 mo (an averaged of 6 (2%) were placed on the spinal cord, and then a few injections (0.1-0.2 ml each) were made directly into the spinal cord at the mo) after spinalization. 3, 4, 6, 132 7, 8, 9 CC6 L 5 , right ventrolateral 11, 54, 56, 103, 195 132 8, 105, 106, 188 4, 6, 9, 11, 27, 119 74, 28, 29, 30, 32, 10, 15, 177, 243 9, 149, 151, 240 7, 72, 119, 164 100, 148, 276, 277 154 CC8 L 4 , central dorsal 3, 11, 70 4, 8, 73 digital camera (Panasonic 5100, shutter speed 1/1,000 s) and re-
Recording procedures and protocol
corded on a video recorder (Panasonic AG 7300). For every re-A few days after the intrathecal catheterization and the implanta-cording session, reflective markers were placed on the bony landtion of EMG electrodes and/or nerve cuff electrodes, cats were marks of the left hindlimb facing the camera: the iliac crest, the placed on the treadmill to record locomotion. This served as the femoral head, the knee joint, the lateral malleolus, the metatarsal baseline controls (the intact trials). After spinalization, before drug phalangeal (MTP) joint, and the tip of the third toe (see Fig. 1 ). injection (predrug trials), and at different intervals after each in-Additional markers also were placed either on the treadmill frame trathecal drug injection (postdrug trials), locomotion and re-or on the trunk of the cat for calibration (10 cm). sponses to mechanical and cutaneous stimulation were recorded.
The kinematic and the EMG data were synchronized by means Experiments were made at two stages after spinalization. The of a digital SMPTE (Society for Motion Picture and Television first was at the early stage (Ç1 wk) after spinalization when there Engineers) time code. The time code was generated by a Skotel was no spontaneous treadmill locomotion yet. These cats are re-time code generator (model TCG-80N) and was recorded simultaferred to as early spinal cats. With time and training, spinal cats neously on the EMG tape and on one audio channel of the VHS can attain a well-coordinated locomotor pattern with full weight tape and was inserted as well into the video images. support and plantar foot placement without drug injection Chau et al. 1998) . These cats will be referred
Electrical stimulation
to as late-spinal cats.
Single pulse of 250-ms duration was delivered (Grass S88 stimu-
Drug injections
lator) at 0.4-0.5 Hz through the cuff electrodes. The stimulation was given either at rest, standing, or sitting. The stimulus signal The different noradrenergic drugs used in these experiments are the was displayed on an oscilloscope together with selected EMGs. neurotransmitter norepinephrine (NE) [4-(2-amino-1-hydroxyethyl)-
The threshold (T) of the stimulation was determined by observing 1,2-benzenediol] from RBI, a 1 -agonist methoxamine [a-(1-amia just detectable response in St at rest. noethyl)-2,5-dimethoxybenzenemethanol] from RBI, a 2 agonists including clonidine (2,6,-dichloro-N-2-imidazolidinylid-enebenzena-
Mechanical stimuli were delivered by tapping the dorsum of the and tizanidine [5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-paw with a custom-made hand-held tapper during the swing phase benzothiadiazol-4-amine] from Sandoz Pharmaceuticals. In two cats of locomotion. The tapper has a microswitch attached to indicate (CC6 and CC8), an a 2 antagonist, yohimbine [(16a,17a)-17-Hythe moment of contact with the surface of the dorsum of the paw. droxy yohimban-16-carboxylic acid methyl ester] from RBI and an
The pulse generated by the switch was recorded on tape and also a 1 antagonist, prazosin [1-(4-amino-6,7-dimethoxy-2-quinazo-linyl)-triggered a light-emitting diode (LED) recorded on the video tape. 4-(2-furanylcarbonyl)piperazine] from Pfizer were used. The range
The stimulus was applied randomly during the swing phase of of doses given during experiments was 4.9-12 mM for NE, 2.0-8.0 locomotion but not exceeding once every three step cycles. mM for methoxamine, 0.4-4.0 mM for clonidine, 1.7-3.4 mM for oxymetazoline, 1.0-3.9 mM for tizanidine, and 2.6 mM for both yohimbine and prazosin. All drugs were dissolved in sterile saline Fast paw shake solution except prazosin, which was dissolved in 20% dimethyl sulfTo elicit a fast paw shake (FPS), the experimenter held the cat oxide, 40% distilled water, and 40% saline. Drugs were injected as in the air and then dipped the paw into a bowl of lukewarm water. a bolus into the spinal cord through the intrathecal cannula. Most While both limb movements and EMG signals were recorded, only bolus injections were of 100 ml, but sometimes cumulative doses were the EMG signal was analyzed for FPS. given with injection volumes ranging from 25 to 200 ml per dose. After each drug injection, a subsequent bolus injection of saline (Ç100 ml) was made to fill the dead space of the cannula and to ensure infusion Data analysis of the drug into the intrathecal space of the spinal cord. The limit of Video images were digitized using two-dimensional PEAK Pervolume given in one session was Ç600 ml.
formance system (Peak Performance Technologies, Englewood, CA). Displacement data, encoded by the x and y coordinates of Locomotion different joint markers, were measured at 60 fields/s (i.e., a temporal resolution of 16.7 ms). From these x-y coordinates, angular joint During the control period, locomotion at different speeds was recorded while the cats walked freely on the treadmill belt. After movements were calculated and could be displayed as continuous angular displacements (running averages of 5 values) for a normalspinalization, the forelimbs of the spinal cat were placed on a platform (Ç2 cm above the treadmill) and locomotion of the hind-ized step cycle or as stick diagrams. Each stick figure was also displaced from the previous one by the distance traveled by the limbs was recorded (see Fig. 1 ). An acrylic plastic (Plexiglas) separator (not shown) was put between the hindlimbs to prevent foot so that the horizontal axis is twice that of the vertical axis. The distance between stick figures is also proportional to the velocity of crossing of the hindlimbs resulting from increased adductor tonus often seen in spinal cats. In the early period postspinalization, the the movement.
EMG data during locomotion were played back on an electroexperimenter lifted the tail of the cat to support the weight of the hindquarters of the cat and to provide equilibrium. With time, the static polygraph (Gould, Model ES 1000) and a typical record of the animal's performance before and after drug injection was secat could walk with complete weight support of the hindquarters, and the experimenter only held the tail to provide equilibrium of lected for analysis. The EMG signals were digitized at 1 kHz.
Using custom-made software, the onset and offset of bursts of the hindquarters.
The EMG signals were amplified differentially (bandwidth of activity were detected first automatically and then corrected manually if needed. The EMGs then were rectified and, using St as the 100 Hz to 3 kHz). Twelve channels were recorded with a video recorder (Vetter Digital, model 4000A PCM recording adapter) onset of the cycle (occasionally Srt), the EMGs were averaged over a number of cycles. The duration and amplitude of the muscle with a frequency response of 1.2 kHz per channel.
Video images of the locomotor movements were captured by a bursts were measured from individual records. The mean amplitude was calculated as the integral of the rectified EMG burst divided spinalization ( Fig. 2A) ]. Another distinct characteristic conby its duration.
sistently observed after clonidine was a pronounced foot EMG responses to the electrical stimulation was digitized at 1 drag during the initial swing phase (Fig. 2C ) that often was kHz and computer averaged. Quantitative measures of the re-followed by a greater elevation of the foot at the end of sponses (amplitude and latency) were obtained using custom-made swing before putting down the foot.
software which integrate the region that was consistently greater
Other a 2 -noradrenergic agonists, tizanidine (n Å 2) and or less than the mean prestimulus period by 2 SD. For mechanical oxymetazoline (n Å 2), were also capable of initiating locostimuli, the individual EMG responses to stimulation were shown motion in early spinal cats within the first week posttransecbefore and after drug injection.
tion. In Fig. 3 , the stance, swing, and cycle duration as well as stance length (measured from kinematic values) in a 3d, R E S U L T S 4d, and 8d spinal cat after injection of clonidine, oxymetazoThe results reported here are from experiments in the five line, and tizanidine, respectively, as well as a 8d spinal cat spinal cats in which different drugs were injected on different after injection of NE are shown. The values are expressed postspinal days as summarized in Table 1 . All analyzed trials as a percentage of intact locomotion because the cats were at different days are underlined. Even though some trials not walking at this early stage posttransection. The three a 2 were not analyzed quantitatively, the videotapes and EMG agonists triggered locomotion similarly by increasing the data always were reviewed to verify the similarities or differ-step cycle duration, especially the swing duration. The locoences of drug effects in different spinal cats. Although a motion initiated by NE was not as good as that triggered by range of doses has been tested, the analyses reported here the a 2 agonists. For example, the stance length was 64% of refer mainly to trials where a dose of 3-4 mM in a bolus the intact locomotion after NE as compared with the 99% of 100 ml was used for all a 1 and a 2 agonists; this seems to after oxymetazoline injection. As shown in Table 2 , although produce optimal locomotor effects. For the antagonists, the cycle duration of the spinal locomotion was very small doses of 2.5-2.6 mM were effective. In the case of NE, a before clonidine injection at 3, 5, and 8d posttransection in higher dose,°12 mM, sometimes was required. The effects cats CC4, CC5, and CC7, respectively, it was 113, 92, and of a drug on locomotion were evaluated at two stages post-135% of intact values within minutes after clonidine injectransection, at an early stage (early spinal) when there was tion. Similarly, after oxymetazoline injection in cat CC8 no spontaneous locomotion (i.e., õ8 days) and at a later at 4d posttransection (3.4 mM it), the cycle duration was stage when the locomotor pattern was already established increased to 129% of intact locomotion. The ability of the (late spinal) before any drug injection. In all early spinal cat to adapt its locomotion to increasing treadmill speed was cats, usually within the first week posttransection, no well-also similar among the a 2 agonists. The maximum speed the organized sustained locomotion can be elicited before drug early spinal cats can achieve after injection of tizanidine (n injection. The ability of the different noradrenergic agonists Å 2), oxymetazoline (n Å 1), and clonidine (n Å 2) injecto initiate locomotion could then be tested.
tion was 0.6-0.7, 0.8, and 0.9-1.0 m/s, respectively. The concomitant EMG changes also are listed in Table  Initiation of locomotion in early spinal cats 2. After all three a 2 agonists, there was an increase in the knee flexor St activity, relatively more than that of the exten-EFFECTS OF a 2 -NORADRENERGIC AGONIST ( CLONIDINE, TIZANIsor activity that contributes to the marked increase in the DINE, OXYMETAZOLINE ) . The ability of clonidine, a wellswing duration. For example in cat CC4, after clonidine known a 2 -noradrenergic agonist, to trigger locomotion was injection, ipsilateral (iSt) burst duration was 247% of intact, confirmed consistently here in four spinal cats and is shown whereas the extensors, iGL and iVL, were 109 and 102% in Fig. 2 . In this 8-day (8d)-spinal cat (CC7), although of intact. Similar results were observed in cat CC7 after there was no locomotion during the predrug trials ( Fig. 2 B) , clonidine injection. After tizanidine injection in cat CC6, almost immediately (within 2 min) after clonidine injection the burst duration of iSt was also much more augmented (3.8 mM it injected as a bolus of 100 ml) a well-organized (230% of intact) than that of the extensors iGL and iVL, locomotor pattern was observed (Fig. 2C ). There was a which are 138 and 126% of intact. After injection of oxymetmarked increase in stance and swing duration comparable azoline, in cat CC8 the coSt burst duration (not shown) was to the intact locomotion ( Fig. 2A) as shown in the stick also 319% of the intact locomotion as opposed to iGL and figures. This remarkable quasi-instantaneous action of iniVL, which are 95 and 122% of intact, respectively. In contrathecal clonidine also was seen in another spinal cat (CC4) clusion, a 2 agonists appeared to have a more potent effects in which locomotion was triggered within 3 min after injecon the hindlimb flexors muscles. tion. The clonidine-elicited locomotion can be characterized Although the three a 2 agonists were similar in their ability as readily triggered, requiring only a light touch to the perito trigger locomotion in early spinal cats, differences in the neum; adaptable to treadmill speeds°1.0 m/s; sustained, evoked locomotor pattern were seen. Although tizanidine i.e., the cat could walk consistently 15-20 min at a time for resembled closely the effects of clonidine, the kinematics a period of 2-3 h; and the effects last for Ç5 h. Although of the locomotor pattern triggered by oxymetazoline was the clonidine-elicited locomotion resembled the intact locodifferent from that of clonidine. For example, the increase motion in many respects, there were also some distinct charin hip flexion was more marked after oxymetazoline injecacteristics. For example, a knee sag often was observed totion as compared with clonidine, and the corresponding hip ward the end of stance as noted in the stick figures [the iliac joint angular excursion was 144 and 87% of intact, respecand hip markers are sloping downwards toward the end of the stance phase, something that is not normally seen before tively. The foot drag was also much more exaggerated after CC7) . A: stick diagram (1-step cycle) and raw electromyographic (EMG) traces of hindlimb flexor and extensor muscles during intact locomotion before spinalization. Treadmill speed at 0.3 m/s. B: locomotion at 8d postspinalization before any drug injection. C: locomotion recorded at 2 min after clonidine injection (4 mM it). Muscle gains of ipsilateral (i) semitendinosus (St) and contralateral (co) St EMG were decreased to 0.4 and 0.5 times the gain of recording in intact cat. FIG . 3. Histograms of cycle duration, stance duration, swing duration, and stance length (obtained form kinematic data) expressed as percentages of intact locomotion in 4 spinal cats: CC4 (3d), CC8 (4d), and CC6 (8d) and CC5 (8d) after intrathecal injection of clonidine (3.8 mM), oxymetazoline (3.4 mM), tizanidine (3.9 mM), and norepinephrine (12.0 mM), respectively. ---, values obtained from the cats during intact locomotion before spinalization. Note that the cats were not walking before the drug injection. Step cycle and burst durations are percentages of intact values obtained before spinalization, iSrt and iSt, ipsilateral sartorius and semitendinous; iVL and iGL, ipsilateral vastus lateralis and gastrocnemius lateralis. * First number is days postspinalization; second number is time after injection.
clonidine injection than oxymetazoline. The ankle joint an-pattern were consistently seen in all experiments, in all spinal cats both during early and late-spinal period (see Table 3 ). gular excursion of clonidine-and oxymetazoline-evoked locomotion were 197 and 137% of intact, respectively. The EFFECTS OF AN a 1 -NORADRENERGIC AGONIST ( METHOXAability of the cat to support the weight of the hindquarter MINE ) . The ability of methoxamine to trigger locomotion was good after oxymetazoline injection as compared with in early spinal cats was much more inconsistent and different clonidine. For example, the knee sag, often observed after from the a 2 -noradrenergic agonists. We have tested the efclonidine was not observed with oxymetazoline.
fects of methoxamine in three early spinal cats, all of which The time course of action among the three a 2 agonists had no locomotor activity before drug injection. was also different as shown in Fig. 4 . The locomotor effects
In two cats (CC5 and CC7), there was a significant inwere evaluated by measuring the stance duration at a speed crease in the ability of the cats to stand on a stationary of 0.6 m/s. Within 5 min after clonidine or tizanidine injec-surface, and to a varying degree, an increase in stepping tion, the cat could walk at 0.6 m/s (Fig. 4A) . Oxymetazo-movements after methoxamine injection. For example, in line, on the other hand, had a much slower onset, taking cat CC5, 90 min after methoxamine injection (Fig. 5B) , hours instead of minutes to reach the maximal locomotor there was an attempt to increase stepping, as seen in the effects (Fig. 4B , note that the time scale is different from EMG traces. In another cat (CC7), 15 min after methoxa- Fig. 4A ). The cat could not walk at 0.6 m/s at 30 min or 2 mine injection, although the increase in stepping ability was h after injection; however, when recording was made on the more pronounced (stance length was 88% of intact), it was next day, a marked increase in the locomotor ability could never as convincing as that observed with a 2 agonists. For be seen. The duration of effects exerted by the three a 2 example, the cats could not walk consistently (¢10 consecuagonists was also different. After tizanidine injection, the tive step cycles) with weight support of the hindquarters or cat could not walk at 0.6 m/s after 2.5 h, whereas after walk beyond 0.2 m/s. In both spinal cats, however, transient clonidine injection, the cat still could walk at this speed even bouts of nice locomotor activity (0.2 m/s) with good weight at 4.5 h, an ability that only diminished at 6.5 h after injec-support and an increase in the amplitude of EMG activity tion. The effects of both clonidine and tizanidine completely in flexors and extensors could be triggered with time (Table  disappeared on the following day. With oxymetazoline, how-2). Figure 5C shows an example of bouts of locomotion ever, locomotion at 0.6 m/s could be maintained for ¢2 (cat CC5) observed at 5.66 h after methoxamine injection. days after drug injection. A marked reduction in locomotion With strong perineal stimulation, this cat could walk with was seen by the third day postinjection where the stance good weight support and plantar foot placement up to 0.2 duration decreased by 40%. We do not, however, know the m/s. The cycle duration and stance length increased to 87 time it takes for the effects of oxymetazoline to completely and 76% of the intact, respectively (see Table 2 ). This was wear off.
the maximal effects observed in this cat and is in sharp contrast with the effect of clonidine given to this cat 2 days The differences in the time course of action and locomotor 4 . Time course of action of the 3 a 2 -noradrenergic agonists. Changes in the stance duration (during locomotion at 0.6 m/s) as a function of time after the injection of clonidine, tizanidine, and oxymetazoline in cats CC4 (3d), CC7 (9d), and CC8 (4d), respectively, were measured to evaluate the effects of the drugs. Note the different time scale between A (clonidine and tizanidine) and B (oxymetazoline). In A, at 2.5 and 6.5 h after tizanidine and clondine injections, respectively, the stance duration was at 0 as the locomotion returned to the predrug nonwalking status. Effects of clonidine and tizanidine completely dissipated on the following day. In B, oxymetazoline took some 2 h to have an effect and lasted for several days.
later (5d posttransection; Fig. 5D ). Sustained organized loIn the same cat, 2 days later, injection of an a 1 -noradrenergic antagonist, prazosin, was found to be effective in comotion (0.4 m/s) with large steps, weight support, and foot placement was readily observed at 1.5 h postinjection blocking the effects of methoxamine on locomotion as shown in Fig. 7 . Within 30 min after injection, there was of clonidine requiring only minimal perineal stimulation.
Thus from the observations of these two cats (CC5 and no plantar foot placement, and instead, the cat continually struck the treadmill with the dorsum of the paw and was no CC7), methoxamine appeared not to be as effective as the a 2 agonists in triggering locomotion. Despite an increase in longer capable of supporting its weight during locomotion.
The step cycle duration and stance length decreased to 45 stepping movements and bouts of organized locomotion with weight support, the cats never could walk beyond 0.2 m/s. and 29% of intact, respectively, as compared with the corresponding values of 105 and 118% of intact before prazosin However, contrary to the above observations, methoxamine was found to be effective in triggering locomotion in injection. The effects of prazosin appears to wear off by 1.75 h after injection. another spinal cat (CC6) at 4 days posttransection as shown in Fig. 6 . Before methoxamine injection, no walking could Thus it suggests that the effects on locomotion seen in this cat (CC6) could be attributed to the effects mediated be triggered on the moving treadmill belt even with strong by NE a 1 receptors. perineal stimulation (Fig. 6B) . Three hours after injection (Fig. 6C) , the locomotor pattern significantly improved and DIFFERENCES IN LOCOMOTION INDUCED BY THE a 1 AND a 2 was robust, requiring only minimal perineal stimulation. The AGONISTS. The locomotor pattern triggered by the a 1 -noradcat could walk with plantar foot placement, support the renergic agonist, methoxamine, differed from that evoked by weight of the hindquarters, take large steps and adapt to a 2 -noradrenergic agonists such as clonidine. In the a 2 -intreadmill speed°0.4 m/s. The step cycle duration and stance duced locomotion, an exaggerated foot drag at the onset of length at 0.4 m/s were 101 and 89% of intact, respectively. swing was a consistent observation (Figs. 2C and 5D) ; in This locomotor ability persisted till the following day (5 contrast, in the a 1 -induced locomotion, there was no foot drag days posttransection). Thus it appears that an a 1 agonist, at the onset of swing (Figs. 5C and 6C ). In the methoxaminemethoxamine, was also capable of initiating locomotion at induced locomotion, the weight support of the hindquarters was also much better than the clonidine-induced locomotion. least in this cat at an early stage postspinalization. Only cats that could walk spontaneously without drugs were included in this table. The doses and the range of postspinalization days are shown. The frequency of observation of different effects if also shown in parentheses. For example, in the case of clonidine, all drug trials (12/12) showed an increase in step duration, step length and marked toe drag, and in 7 of 7 experiments where responses to electrical stimulation were tested, there was either an increase in the threshold (T) of stimulation at rest (standing) or a decrease in the reflex response with the same stimulation intensity. All stimulating parameters (frequency, 0.4 Hz, pulse duration, 250 ms) were kept constant before and after drug injection. * Number of experiments. This is reflected partially by the absence of knee sag in the 5D). As shown in the stick diagram (Fig. 6C) , the iliac and hip trajectory remained leveled and no knee flexion was seen methoxamine-induced locomotion (Figs. 5C and 6C) as compared with the clonidine-induced locomotion (Figs. 2C and at the end of stance, both of which often were observed after FIG . 5. Effects of an a 1 agonist, methoxamine, on a spinal cat (CC5) at 3d posttransection as compared with the effects of clonidine (a 2 agonist) on the same cat at 5d posttransection. A: locomotion before methoxamine injection. B: 90 min after methoxamine injection the cat had rhythmic movements of the knee but very little movements of the hip. Hindlimb was being dragged on the treadmill with the paw behind the hip joint. C: 1 bout of locomotor activity at 0.2 m/s could be observed at a longer time interval after injection of methoxamine (5.66 h). Note that the EMG activity in the proximal muscles is still not well organized at least on the contralateral side. D: in contrast to the effects of methoxamine, 90 min after clonidine injection in the same spinal cat 2 days later (5d posttransection), there was a well-organized locomotion at a treadmill speed of 0.4 m/s characterized by large alternating steps and well-developed EMG activities of the hindlimbs even in the more proximal muscles such as sartorius (Srt) A: locomotor pattern during intact condition at 0.4 m/s. B: no locomotion was seen before methoxamine injection. C: 3 h after methoxamine injection (4 mM it), organized locomotor pattern was recorded at the same treadmill speed as the intact locomotion. Alternating EMG bursts of activity were observed in the hindlimb muscles, whereas the hip flexor Srt of both hindlimbs showed more or less tonic activity.
clonidine injection (Figs. 2C and 5C ). The extensor activity dine with the exception of oxymetazoline, which also produced long-lasting effects. of hindlimb muscle was also much increased after methoxamine injection as compared with after clonidine injection.
Therefore, differential effects were observed with a 1 and After methoxamine injection in cats CC5 and CC6, at 3d a 2 agonists with respect to the locomotor pattern, EMG acand 4d postspinalization, the VL amplitude were 150 and tivity, the weight support ability and the time course of 190% of intact, and the GL amplitude were 161 and 163% action. of intact, respectively. After clonidine injection in cat CC4 EFFECTS OF NORADRENALINE. Noradrenaline also was capaat 3d postspinalization, the amplitude of VL and GL was ble of triggering locomotion in the early spinal cat (CC8). 97 and 117% of intact, respectively. Also, in the clonidine- Figure 8 shows the locomotor pattern of the 8d-spinal cat induced locomotion (Fig. 2C) , the activity of proximal mus-(CC5) during intact, predrug, and postdrug period. There cle such as the hip flexor, Srt, was well organized (Figs. was no locomotion before drug injection (Fig. 8B) . Loco-2C and 5D). In the methoxamine-induced locomotion, no motion with plantar foot placement began at 40 min after organized Srt bursting activity can be seen at this stage but NE injection (not shown; 12 mM it). The pattern was tranevolved with time (Figs. 6C and 8C) . sient, and with time it became more robust, and by 1 h, the The initial ability of the early spinal cats to follow the cat could walk with plantar foot placement and weight supmaximal treadmill speed was also different. After methoxaport of the hindquarters (Fig. 8C) . The raw EMG traces mine injection, the maximum treadmill speed that cat CC6 showed alternating bursting between the different hindlimb (4d) could follow was only at 0.4 m/s as compared with flexor and extensor muscles. The locomotion was characterthe clonidine injection, where the maximum speed cats CC4
ized by steps shorter than in the intact. The step cycle dura-(3d) and CC8 (3d) could follow was 0.8 and 0.6 m/s, retion and the stance length of the NE-triggered locomotion spectively. However, with time (6d posttransection), cat were 58 and 72% of the intact locomotion, respectively. CC6 also could adapt to 0.6 m/s after methoxamine injecThus it appears that although NE readily triggered robust tion. Finally, the time course of actions are also different. locomotion in early spinal cats similar to a 2 agonists, the The effects of the a 1 agonist methoxamine were much longer lasting as compared with the a 2 agonists clonidine and tizani-effects were less potent than a 2 agonists as shown in Fig.   J871 Locomotor effects of the a 1 agonist methoxamine as shown in the previous figure was blocked by an a 1 antagonist, prazosin. A: in spinal cat CC6, at 6d posttransection, no locomotion was seen before drug injection. B: 3 h after methoxamine injection (4 mM it), the cat could walk with weight support and plantar foot placement at a treadmill speed of 0.4 m/s. C: injection of prazosin markedly reduced the step amplitude 34 min after, and the rhythmic movements were confined to the knee and the ankle. Gain of coSt shown in B and C was increased 2.5 times relative to the predrug trials.
3. In addition to exerting partial a 2 effects, there was also in the step length (117% of predrug) as shown in the stick no foot drag or knee sag observed in the NE-induced loco-figures (Fig. 9D) , and an increase in the angular excursion motion; this also resembled the effects observed with a a 1 -in all joints, in particular the knee and ankle joint, as shown noradrenergic agonist. It appears then that mixed a 1 and a 2 in the joint angle plots (Fig. 9E ). An exaggerated foot drag effects could be evoked by NE as could be expected.
at the onset of swing, resulting from an inadequacy to clear the ground during foot lift, also was observed as shown in the stick diagrams. The amplitude and duration of the flexor Modulation of locomotion parameters in late-spinal cats (Ip, Srt) muscles were increased; this may contribute to the In late-spinal cats, when the cat was capable of spontane-increase in swing duration. The duration of the extensor ous locomotion, the ability of these drugs to modulate the (GM and VL) bursts also was increased, contributing to an already established locomotor pattern and their effect on increase in stance duration after tizanidine injection; howcutaneous reflex excitability was assessed. The cutaneous ever, the amplitude of the ankle extensors GM was decreased reflex excitability of the hindlimbs was assessed by the re- (Fig. 9F) , which might explained partially the decrease in sponse to mechanical and electrical stimulation as well as weight support of the hindquarters. The fact that these loco-FPS. The effects of the drugs on locomotion and cutaneous motor effects of tizanidine were mediated by a 2 adrenocepreflex in all spinal cats and different experimental trials are tors was further supported by the ability of yohimbine, an summarized semiquantitatively in Table 3 .
a 2 -adrenoceptor antagonist, to block the effects (Fig. 9G) . As soon as 15 min after yohimbine (2.5 mM it) injection, MODULATORY EFFECTS OF a 2 AGONISTS. All three a 2 agothere was a decrease in step length. The cycle duration denists, clonidine (12 injections), tizanidine (7), and oxymetacreased by 10% of the predrug trial, the swing duration zoline (7), could modulate the locomotor pattern in a similar decreased by 20% of the predrug trials, the weight support fashion (Table 3 ). Figure 9 shows an example of the effects increased with a corresponding increase in the ankle extensor of tizanidine on locomotion in a 157d spinal cat (CC8).
GM activities (26% of the predrug trials), and the exaggerBefore any drug injection, the locomotor pattern was well ated foot drag disappeared. established with full weight support and plantar foot placeAlthough the three a 2 agonists (clonidine, tizanidine, and ment (Fig. 9A) . Thirty minutes after the injection of tizanidine (cumulative dose 4.8 mM), there was a marked increase oxymetazoline) modulated the cycle duration and step length of locomotion of late-spinal cats similarly, some differences As seen in the stick diagrams (Fig. 10D) , there was no were noted (see Table 3 ). For example, the weight support apparent increase in stance or swing duration as compared ability was more affected after clonidine injection as com-with the predrug trials. There was no foot drag nor knee pared with oxymetazoline and tizanidine injection. The de-sag at the end of stance (both are commonly seen with a 2 crease in weight support ability was seen in 75% of trials agonists). Also, there was little differences in the angular tested with clonidine, whereas the weight support ability was excursion before and after methoxamine injection (Fig. 10 , largely unchanged after oxymetazoline injection. Three of B and E). There was, however, a marked increase in the seven trials (42.8%) after tizanidine reported a decrease in EMG amplitude of the knee and ankle extensors, VL and weight support ability. Also, the degree of side effects pro-GL (163 and 130%, respectively, of the predrug values), duced by these a 2 agonists in late-spinal cats were different. and the proximal hip extensor, Glu (increased fivefold). The Both clonidine (3.8 mM it) and oxymetazoline (3.4 mM it) burst duration of the Glu also was increased to 210% of the often produced some side effects (vomiting, dilated pupil, predrug value. The overall increase in the extensor muscle lethargy) but tizanidine never did (4.7 mM it). These obser-activity could contribute to the increased extensor tonus and vations were seen consistently in four spinal cats.
resulted in a more rigid posture with extended hindlimbs. Figure 10 , G-I, shows the combined effects of methoxa-MODULATORY EFFECTS OF METHOXAMINE. Figure 10 shows mine and clonidine on locomotion in the same cat. Clonidine an example in cat CC6 of a methoxamine injection alone was injected to the same cat within 2.78 h of the methoxa- (Fig. 10, D-F) followed by a superimposed injection of mine injection, after marked effects of methoxamine were clonidine (Fig. 10, G-I) , allowing us to describe the moduobtained. Ten minutes after clonidine injection, the stance latory effects of the combination of an a 1 and an a 2 agonist. and swing duration increased to 119 and 143%, respectively, After methoxamine injection (4 mM it), there was a of the preclonidine values (Fig. 10G) . Although an exaggermarked increase in the extensor tonus of the hindlimbs and ated foot drag during the initial swing period was seen, there the joints appeared stiffer when the cat was standing (not was no knee sag at the end of stance as often observed after shown). There was also some obvious spontaneous moveclonidine. This may be related to the increased extensor ments of the tail that were absent before. However, methoxatonus. In addition, burst duration of flexors such as St and mine did not significantly modulate the well-established locomotor pattern in late-spinal cats (11 injections; Table 3 ). coSt were increased to 282 and 176%, respectively, of the predrug value. The amplitude of the extensor muscle such was observed in both tizanidine-and NE-induced locomoas iVL and iGL, although slightly decreased as compared tion but not in methoxamine-induced locomotion. Also simiwith after methoxamine injection, remained high at 131 and lar to tizanidine-modulated locomotion (Figs. 9E and 11D) , 100% of the predrug values, respectively. The proximal hip the angular excursions of all joints, in particular, the knee, extensor, Glu burst amplitude and duration also remained ankle, and MTP joint, angular excursion were increased sighigh at 637 and 189% of the predrug value, respectively. nificantly after NE injection (Fig. 11K ). These observations Thus the resultant locomotor pattern showed a summation were consistently seen in three different spinal cats. Normalof effects mediated by both a 1 and a 2 agonists.
ized EMG showed that after NE injection, the knee flexor St burst duration and amplitude increased to 139 and 143% MODULATORY EFFECTS OF NORADRENALINE. The NE-moduof the predrug value, respectively, resembling the tizanidinelated locomotor pattern also resembled (6 injections) the induced locomotion. On the other hand, the NE-modulated combined effects of a 1 and the a 2 agonists (Fig. 11, J-L) .
locomotion also resembled the a 1 -modulated locomotion in Twenty-three minutes after NE injection (4.9 mM it) there some respects. For example, there was no knee sag at the was a significant increase in the stance and swing duration end of stance (Figs. 10D and 11G) . Also, the amplitude of (Fig. 11J ) similar to that seen with the a 2 agonist tizanidine the knee and ankle extensors increased to 287 and 229% of (Fig. 11B) injected in the same spinal cat (CC7) at a differthe predrug value, respectively (Fig. 11I) , which was similar ent postspinal day. This is in contrast with the a 1 agonist methoxamine with which there are no significant changes in to the methoxamine-modulated locomotion (Fig. 10F) . Figure 12 summarizes the percentage change of the step the stance and swing duration was seen (Figs. 11C and  10D ). An exaggerated foot drag during initial swing also cycle, stance, and swing duration in all cats after injection of a 2 agonists, one a 1 agonist, and norepinephrine. Similar especially the proximal hip extensor such as Glu. The effects on locomotion after injection of NE resembled a combined effects were observed in the three a 2 agonists (Fig. 12, A-C) . The increase in step cycle duration ranges from 20 to effects of a 1 and a 2 agonists. 40% of the predrug trials and the increase in swing duration ranges from 30 to 80% of the predrug trials, whereas the Modulation of cutaneous reflex excitability in late-spinal increase in stance duration ranges from 10 to 40% of the cats predrug trials. Thus a 2 agonists increased the swing duration more than the stance duration. Similar to the a 2 agonist, the In addition to changes observed in the locomotor pattern increase in swing duration after NE injection ranges from in cats after drug injection, there were also concurrent 116 to 166% of the predrug trials in three experiments done changes in the excitability of the cutaneous pathways as in spinal cats CC7 and CC8.
seen with mechanical or electrical stimulation and FPS. The In contrast, after methoxamine injection (Fig. 12D) , there results obtained from all spinal cats also are summarized in was very little changes in all three cats with respect to the Table 3 . step cycle duration, stance, and swing duration as compared with the a 2 agonists. However, the a 1 agonist methoxamine MECHANICAL STIMULATION. The a 2 agonists clonidine and oxymetazoline markedly reduced or abolished the response exerted marked effects on increasing the tonus and the weight support of the hindquarters of the cat, possibly by to tap in 100 and 67%, respectively, of all trials tested (Table  3) . Tizanidine, also decreased the response to tap but to a increasing the amplitude and duration of extensor muscles lesser extent; the reflex amplitude was decreased in 50% of the cutaneous reflex remained excitable (resembling the effects of methoxamine). the trials but remained unchanged in 50% of the trial.
An example of the response to tap is shown in Fig. 13 . ELECTRICAL STIMULATION. Although a 2 agonists consisBefore clonidine (Fig. 13A) , as soon as the tapper touched tently ( 7 injections ) increased the threshold of stimulation the paw there was a brisk response, i.e., a rapid knee, ankle, or decreased the reflex response to electrical stimulation, and MTP flexion, shown in the stick figures to clear the the a 1 agonist ( 4 ) and norepinephrine ( 6 ) reduced the obstacle. Note that on the video records, the tapper was seen threshold and increased the reflex amplitude ( Table 3 ) . in contact with the dorsum of the paw in only one frame (2 Figure 14 shows an example of the activation of flexors fields) indicated by one arrow. After clonidine, the brisk and extensor muscles during the electrical stimulation of response to tap also disappeared as previously reported the superficial peroneal nerve before and after drug injec- ). On contact with the tapper, the knee tion in the same cat, CC7, at rest ( standing ) . After clonifailed to flex; instead the paw pushed continuously onto dine injection ( Fig. 14 A ) , there was also a marked dethe tapper and eventually, by inertia, the limb continued its crease in the amplitude of the short latency response in trajectory.
the knee flexor St despite a much stronger stimulating In contrast to the a 2 agonists, the a 1 agonist (11 injec-current. Before clonidine, a current of 0.75 mA was suffitions) and NE (5) did not reduced the response to tap in cient to activate St. After clonidine, St was not activated any of the tested trials. As shown in Fig. 13B , in the same even with a current as high as 3 mA, i.e., four times the cat, CC4, after methoxamine, there were no marked changes strength used before clonidine injection. in the swing duration, and the response to tap was still presOn the contrary, the short-latency response in St was augent. NE appeared to exert effects of both a 1 and a 2 types. mented after both NE and methoxamine (Fig. 14, B and C) As shown in Fig. 13C , there was both a marked increase in with the stimulating parameters being kept constant before and after the drug injection. the swing duration (resembling the effects of clonidine) and J871-7 / 9k29$$ju14 05-19-98 05:21:19 neupa LP-Neurophys active and the cats could walk on the treadmill. Thus a decrease in the reflex transmission rather than a decrease in excitability at the motoneuronal level is more likely to contribute to the attenuation of the short-latency cutaneous response.
FAST PAW SHAKE. With a 2 agonists, FPS was abolished with clonidine (12 injections), oxymetazoline (5), and tizanidine (3) ( Table 3 ). Figure 15 shows an example of the FPS before and after drug injection in three different spinal cats. In a 62d spinal cat, 15 min after clonidine, the FPS disappeared (Fig. 15A) . On the contrary, after methoxamine (11 injections), the frequency of the FPS was enhanced (10 Hz; Fig. 15B ). The frequency range of the FPS was within the range previously reported for spinal cats (Pearson and Rossignol 1991; Smith et al. 1985) . Similarly, after NE (3 of 5 trials), the FPS response was still present. Thus with NE, although the locomotor effects seemed to resembled the a 2 agonist as mentioned before, the cutaneous effects resembled the a 1 agonist.
SUMMARY OF MODULATION OF THE EXCITABILITY OF CUTA-
NEOUS PATHWAYS IN LATE-SPINAL CATS. Methoxamine (a 1 agonist) and NE consistently increased the cutaneous excitability in four spinal cats (see Table 3 ). The three a 2 agonists (clonidine, tizanidine, and oxymetazoline) reduced the excitability of cutaneous reflex of late-spinal cats to a different FIG . 12. Histograms showing the modulatory effects of 3 a 2 agonists (clonidine, oxymetazoline, and tizanidine), the a 1 agonist methoxamine, and NE on the cycle, stance, and swing duration in different late spinal cats. The cycle, stance, and swing duration were expressed as percentages of the predrug trials. Comparison of responses to electrical stimulation of the superficial peroneal nerve of cat CC7 at rest (standing) after different drugs. A: averaged response of 20 and 10 stimuli before and after clonidine injection, respectively. Current delivered before clonidine injection was 0.75 mA and was 3.0 mA after injection. No response can be seen even at this current. B: averaged response of 9 and 10 stimuli before and after methoxamine, respectively. Current of the stimulation stayed the same (0.6 mA) before and after methoxamine injection. C: averaged response to 10 and 15 stimuli before and after NE injection, respectively. Current of stimulation before and after NE injection was 0.5 mA.
extent. Among the three noradrenergic agonists, clonidine D I S C U S S I O N was the most potent one in reducing the cutaneous excitabil-Summary of the results ity. It consistently and markedly increased the threshold of electrical stimulation, and it abolished both FPS and rea 2 -Noradrenergic agonists (clonidine, tizanidine, and oxysponses to tap. Oxymetazoline and tizanidine, on the other metazoline) and the a 1 -noradrenergic agonist (methoxamine) hand, did not reduce the excitability of the cutaneous reflex appear to have different effects on spinal locomotion. First, a 2 -as markedly as clonidine (Table 3) . For example, tizanidine noradrenergic agonists were all capable of initiating locomotion only reduced the response to tap in 50% of trials tested. It in cats within minutes during the first week after spinalization, slightly increased the threshold of electrical stimulation in whereas the a 1 -noradrenergic agonist was not as effective. In 67% of the trials and did not change the threshold in the the one case in which it clearly triggered locomotion (cat CC6), it took ¢2-3 h before the effects could be seen. Second, remaining 33% of the trials. although all a 2 -noradrenergic agonists modulated the already The ability of NE to initiate locomotion in our study was well-established locomotor pattern in late-spinal cats similarly, also consistent with study of others (Kiehn et al. 1992 ). Our such as increasing markedly the angular excursion, step cycle findings also show that other a 2 agonists such as tizanidine duration, in particular, the swing duration, the a 1 -noradrenergic and oxymetazoline can initiate locomotion. Their action posagonist methoxamine did not. Third, a 2 -noradrenergic agonists sibly is mediated through postsynaptic a 2 adrenoceptors as decreased the cutaneous excitability as opposed to a 1 agonist, spinalization resulted in the degeneration of presynaptic terwhich increased the cutaneous excitability. Fourth, in contrast minals and receptors, and yohimbine could block the effects. to the a 1 -noradrenergic agonist, which increased the weight Although less consistent than the a 2 agonist, the a 1 agonist support of the hindquarters, the a 2 -noradrenergic agonists did has been shown to be capable of initiating locomotion in not or sometimes decreased the weight support of the hindquar-one early spinal cats possibly through the actions on the a 1 ters. Fifth, a 2 -noradrenergic agonists consistently exaggerated adrenoceptor because the effect was blocked by prazosin, the foot drag seen at the onset of swing and a 1 -noradrenergic an a 1 blocker. agonists did not. Last, some degree of differences in weight
The mechanisms on how the specific noradrenergic agosupport ability and cutaneous reflex modulation were observed nists initiate locomotion is unclear. Our findings suggest that among the three a 2 agonists. NE, as expected, exerted both a 2 although activation of both a 1 and a 2 receptors can initiate and a 1 effects; that is, on one hand, it initiated locomotion in locomotion, the actions of the a 1 receptor appeared to be the early stage and prolonged the step cycle (a 2 effects) while more involved with increasing the output amplitude of the preserving cutaneous reflex excitability (a 1 effect). Although muscle, whereas the a 2 receptors are more involved with NE increased the hindlimb flexor activity (a 2 effect), it also control of the rhythm of the locomotor pattern. increased the extensor activity of the hindlimbs (a 1 effect).
The differential effects of a 1 and a 2 agonists are more evident in late spinal cats when they were already walking Effects of noradrenergic agonists on locomotion before any drug injection. a 2 -adrenoceptor activation modulated significantly the timing of the muscles, especially the Effects of the clonidine reported here agree with earlier findings . flexors, whereas activation of a 1 adrenoceptors modulated the timing of muscle activation to a much lesser extent (Fig. 1986) . The depressant effects of clonidine on motoneurons may partially explain the reduced weight support in our late-12). For example, a relatively small dose of clonidine (0.4 mM it) increased the duration of the St by 30% in a cat CC7. spinal cats after clonidine injection.
In addition to differential effects on locomotion, a 1 and a 2 In contrast, the a 1 agonist increased the output amplitude of the extensor muscles to a much greater extent than the a 2 agonists were found to affect other spontaneous movements differently. For example, the spontaneous tail movements we agonist. Thus it is possible that while a 2 agonists exert effects primarily on interneurons that coordinate the timing between observed after methoxamine injection might be analogous to the ''spontaneous tail-flicks'' observed in rats by others the flexor and extensor muscles, a 1 agonists may act also on motoneurons. The effects of a 1 agonist may be similar, (Bervoets and Millan 1994) induced by 5-HT1A receptors.
They reported that a 1 and a 2 adrenoceptors also were found to some extent, to our previous work on the modulatory effect of serotonin (5-HT) agonists or its precursor, 5-hydro-to mediate and inhibit, respectively, the 5-HT1A receptorinduced spontaneous tail-flick response in rat lumbar spinal xytryptophan (5-HTP), which significantly increased the output amplitude of preexisting muscle activity but failed to cord. initiate locomotion .
Plateau potentials causing long-lasting excitability in-Localization of a 1 -and a 2 -noradrenergic receptors in the crease has been reported in motoneurons of cats and turtle spinal cord (Conway et al. 1988; Hounsgaard et al. 1988; .
The differences in localization of these two receptor subThey are induced by L-DOPA, clonidine, or 5-HTP and by types within the spinal cord could reflect their different func-N-methyl-D-aspartate (NMDA) and 5-HTP in interneurons tional roles. a 2 receptors are found predominantly at the in rats . Plateau potentials are suggested dorsal horn, substantia gelatinosa, and the intermediate zone, to be of major importance in providing an increase in the gain close to the central canal, and a 1 -receptors are found also of motoneuronal activity. These unique active membrane in high density in the motoneuron area in the ventral horn properties have been implicated to be important in generating (Giroux et al., 1995; Pascual et al. 1992; Roudet et al. 1993 , and shaping motor rhythm. In addition to serotonergic drugs, 1994). Spinal a 1 receptors also were found to become super-L-DOPA and clonidine also have been found to induce plasensitive after deafferentation, suggesting that the receptors teau potential in flexor and extensor motoneurons in spinal are located postsynaptically to NE fibers or terminals cats (Conway et al. 1988) . The plateau potentials in moto- (Roudet et al. 1993) . The presence of a 1 receptors in the neurons was reported to contribute to the late long-lasting hindlimb motoneuronal area may indicate the importance of reflexes observed in spinal cats after L-DOPA injection. Ala 1 receptors in modulating the motoneuronal excitability, though clonidine was shown to induce plateau potential in whereas the predominant localization of a 2 receptors in the motoneurons, suggesting the activation of a 2 receptors, we dorsal horn may explain their role in reducing the excitability cannot exclude the possibility of activation of a 1 receptors of the cutaneous reflex. with higher doses of clonidine. Until now there was no information regarding the effects of specific a 1 agonists on spinal motoneuron. a 1 adrenoceptors, however, have been found Effects of noradrenergic agonists on cutaneous excitability to mediate plateau potential in smooth muscles in periphery (Venkova and Krier 1995) .
In this study, although clonidine reduced the excitability of the cutaneous pathways, methoxamine and NE enhanced Noradrenergic drugs also were found to exert excitatory effects on spinal motoneuron (Ault and Evans 1978; White it (increase in the response to tap and FPS and a decrease in threshold for electrical stimulation). The FPS response, et al. 1991) and interneurons (Weight and Salmoiraghi 1966) . The facilitation was found to be mediated by a 1 a high-frequency synchronous activity of flexor and extensor muscles also was reported in fictive preparation (Pearson and receptors as the effects can be abolished by the a 1 antagonist, prazosin. Furthermore, in the presence of prazosin, clonidine Rossignol 1991) was reduced by a 2 agonists and frequency augmented by a a 1 agonist or NE. These facilitatory effects reduced the motoneuronal discharges, which can be antagonized by yohimbine (Hirayama et al. 1988 ). Thus it is sug-of methoxamine and NE were likely to be mediated by the a 1 excitatory actions (Sakitama 1993). gested that the facilitation and suppression exerted by NE was mediated by a 1 and a 2 receptors, respectively (for reOn the other hand, after clonidine, cutaneous reflex excitability was decreased markedly. This is in accordance with view, see Ono and Fukuda 1995) .
In our study, after methoxamine injection in late-spinal earlier studies, which also showed that clonidine (intraperitoneally) reduced significantly the cutaneous excitability in cats, there was an increase in the extensor tonus of the hindlimb, an increase in the stiffness of the joint, an increase in chronic spinal cat . Also, early studies by Lundberg and colleagues showed that DOPA depressed the amplitude and sometimes the duration of the extensors muscles, and a marked increase in weight support of the the short-latency reflex evoked by the flexor reflex afferent (FRA) (Anden et al. 1966b ). The other a 2 agonist, tizanihindquarters. It is possible that these effects were partially due to the increased level of motoneuronal excitability medi-dine, also has been reported to dose dependently reduce the EMG response of the flexor reflex induced by stimulation ated by a 1 adrenoceptors. Rawlow and Gorka (1986) also reported an increase in the anterior tibialis muscle tonus after of cutaneous afferents in awake, nonanesthetized monkeys (Corboz et al. 1991) . The inhibitory effects can be prevented the injection of a selective a 1 -receptor agonist, St 587 in spinal rats. Clonidine, mediated by a 2 adrenoceptors, also by pretreatment of yohimbine, confirming that the depressant effects were mediated a 2 receptors. was found to reduce the excitability of motoneuron and the tonic activity of the hindlimb muscles (Tremblay and Bedard a 1 and a 2 receptors also have been reported to facilitate J871-7 / 9k29$$ju14 05-19-98 05:21:19 neupa LP-Neurophys and inhibit flexor reflex evoked by the group II muscle affer-of ¢30 ms) can change to facilitation after spinalization in rats (Chen et al. 1987; Kehne et al. 1985) . Here, we meaent, respectively (Sakitama 1993) . Their differential effects may contribute to the differential effects they exert on the sured only the short-latency reflex (latency of Ç10 ms) evoked by stimulating the low-threshold cutaneous afferent ability to support the weight of the hindquarters. In anesthetized spinal rats, it has been shown that although a low dose and thus a direct comparison of the fore-mentioned studies (ú30 ms) cannot be made. However, it is possible that a of NE inhibited the flexor reflex evoked by group II afferents, a higher dose of NE facilitated the reflex. In spinal rats a 1 agonist, given at a high dose, also may exert its action on a a 2 adrenoceptor and vice versa. Finally, among the a 2 pretreated with yohimbine, the effects of a low dose of NE shifted from inhibition to facilitation. Also in these rats, adrenoceptors, there exists at least four different subtypes, a 2A , a 2B , a 2C , and a 2D , and the a 2 agonists have different prazosin injection dose dependently antagonized the facilitation effects. Thus NE exerts a facilitation and an inhibition affinity to these different subclass (for review, see Ruffolo et al. 1993 ). on the flexor reflex evoked by group II afferents through the activation of a 1 and a 2 receptors, respectively (Sakitama Therefore, in light of these complex receptors interactions and properties, it is difficult to understand in simple terms 1993). Other studies have shown that clonidine depressed the transmission of group ll muscle afferents to either the the possible functions mediated by the a 1 and a 2 agonists on locomotion. However, our results clearly indicated almost motoneurons or the first-order interneurons in cats (Bras et al. 1990; Schomburg and Steffens 1988) . It is thus possible opposite effects between the a 1 and a 2 agonists. For example, we observed a consistent finding that clonidine inhibited that the decrease in the transmission of group II afferents, via the activation of a 2 receptors, will decrease the tonic the cutaneous reflex, but methoxamine and NE enhanced it . Therefore, it was unlikely that clonidine was activity of the stretch receptors, thus reducing the weight support ability and spasticity (Eriksson et al. 1996) of the acting on the a 1 -receptor.
Recently, a 2 agonists with imidazoline structures have spinal cat.
been shown also to act on the noradrenergic, imidazoline receptors (Nicholas et al. 1995; Ruggiero et al. 1995) . It Foot drag was reported in rats that the imidazoline receptors did not The marked foot drag during initial swing consistently mediate the antinociceptive action of clonidine (Monroe et observed after clonidine injection might in part due to the al. 1995). However, because there is little known about decrease in the transmission of cutaneous afferents. The de-the role of imidazoline receptors, we cannot rule out the crease in cutaneous excitability may decrease the efficacy possibility that a 2 agonists may exert some of its effects of the ''compensatory mechanism'' whereby tactile stimula-through their activation. tion of the dorsum of the foot, an additional flexion, normally is evoked in the spinal cat during swing (Forssberg 1979) . Long-term effects Other contributing factors may be related to the changes in the timing of the recruitment of muscles. For example, after
Oxymetazoline was the slowest acting drug among the spinalization, the ankle flexor TA was found to be activated three a 2 agonists tested but also the longest lasting one (Fig. sooner than the knee flexor St, and the hip and knee flexors 3). The delayed onset of oxymetazoline may be related to its were activated almost synchronously (Barbeau and Rossig-low lipid solubility (Sherman et al. 1987) . Oxymetazoline is nol 1987; Chau et al. 1998) . Collectively, these results in the also resistant to catabolism by monoamine oxidase and does paw moving forward before being adequately lifted, which not cross the blood brain barrier; these might contribute results in the foot drag during swing (Belanger et al. 1996) . collectively to the prolonged effects.
The long latency and duration of effects of methoxamine was suggested to be related to its pharmacological property Possible changes in receptor-mediated function after (Marks et al. 1990 ). For example, methoxamine has a high spinalization affinity but low activity at the a 1 adrenoceptor; it is also removed slowly from the site of action due to the low affinity It is known that after spinalization, which removes all descending monoaminergic terminals, changes of the post-to the amine uptake system.
Other mechanisms contributing to the long-terms effects synaptic receptors will occur. One of these changes is the development of receptor supersensitivity (Barbeau and Be-include the possible changes in some early immediate gene (IEG) expression mediated in part by norepinephrine which dard 1981; Roudet et al. 1993 Roudet et al. , 1994 . Noradrenergic receptors have been reported to become supersensitive, and func-may mediate some long-term CNS changes such as learning.
Activation of a 2 receptors was shown to mediate an inhibitional supersensitivity was attributed to an increase in the number of receptors (Nygren and Olson 1976; Roudet et al. tory influence on the IEG expression in rat forebrain, whereas the a 1 agonist did not inhibit or increase the expres-1993, 1994) and a loss of an uptake system (removal of the descending terminals) (Hirayama et al. 1991) . The specific-sion c-fos gene in the both the cortex and pineal gland (Bing et al. 1991; Carter 1992; Shen et al. 1995) . ity of these supersensitive receptors are likely to remain unchanged (Hirayama et al. 1991 ). However, it is possible NE also has been shown to enhance the long-term potentiation (LTP) in rat hippocampal slices (via b-adrenoceptor) , that the physiological response that they mediate may be different from the intact state depending on the changes in suggesting the possible role of NE in memory acquisition (Hopkins and Johnston 1988) . A combined partial block the receptor sensitivity or efficacy. For example, it has been reported that the depressant effects of clonidine and tizani-of a 1 adrenoceptors and NMDA receptors also decreased learning (Riekkinen et al. 1996) . It also has been suggested dine on the long-latency polysynaptic flexor reflex (latency J871-7 / 9k29$$ju14 05-19-98 05:21:19 neupa LP-Neurophys that a 1 adrenoceptors may interact with the NMDA receptors intrathecal NE, it deteriorated 25 min after clonidine injection (40 mg it) with flaccid paresis of the legs. Recently, in activity (Klarica et al. 1996) . Therefore, we cannot exclude the possibility that the long-term effects described here with our laboratory, while cats with partial spinal lesion that already had recovered voluntary quadrupedal locomotion intrathecal injections of noradrenergic agonists may be exerted through changes in gene expression or complex interac-showed a deterioration in the locomotor performance after clonidine (25-150 mg/100 ml) and improvement after methtions with other membrane receptors.
oxamine (50-150 mg/100 ml) (Brustein et al. 1996) , cats with a complete spinal lesion that had residual locomotor Significance of intrathecal delivery of drug deficits showed a marked improvement in the locomotor The use of an intrathecal catheter for drug delivery is pattern after clonidine (10-100 mg/100 ml) (Rossignol et advantageous for obvious reasons. First, it reduced markedly al. 1995). the side effects of the a 1 -and a 2 -noradrenergic agonists. In
In light of these conflicting and limited therapeutic effects our study, although some side effects (such as gagging or of clonidine, it is essential to better understand the mechavomiting) were occasionally still observed with clonidine nism of clonidine and the receptors involved in mediating (3.8 mM) and oxymetazoline (3.4 mM), especially in late-the specific effects. It is also necessary to explore different spinal cats, the side effects were less severe than after intra-a 2 agonists as each of the a 2 agonists differ in their physioperitoneal clonidine. In the case of methoxamine (4.0 mM chemical properties (Ruffolo and Hieble 1994; Timmermans it) , no side effect was observed. This is in sharp contrast and van Zwieten 1981). By testing different a 2 agonists, it with methoxamine given intraperitoneally (5 mg/kg) in nor-is possible to select a drug that will offer greatest therapeutic mal cats in which severe side effects including restlessness potential while minimizing other undesirable effects. As and hyperventilation were observed in one case. In addition, shown in our findings, although all three a 2 agonists could for the first time, an immediate action of a 2 agonists such initiate locomotion in early spinal cats, differences with reas clonidine and tizanidine directly on the spinal cord neu-spect to modulation of weight support ability and cutaneous rons was demonstrated with the use of an intrathecal cannula. excitability were seen among them (see Table 3 ). Although in the previous paper (Chau et al. 1998 ) the effects It is also important to better understand the specific effects of clonidine were not recorded until 30 min after the intrathe-of the noradrenergic agonist to better target the functional cal injection, in the present paper, the remarkable locomotor deficits. For example, although clonidine may exert imeffects elicited by clonidine in early spinal cats (n Å 2) was portant effects on the generation of the locomotor rhythm observed as early as 1-2 min after injection, suggesting its and increase the cycle duration, it may not be as useful to potent effects on the neural circuitry for the generation of improve postural deficits as it decreased the weight support locomotion. Such immediate effects can never be ascertained and cutaneous excitability. The use of another a 2 agonist that by intraperitoneal injection due to inherent delays.
has less depressant effects on cutaneous reflex and weight support, such as tizanidine, may be a better choice. In addition, although patients with neurological deficits manifesting Clinical significance spasticity may benefit from clonidine in reducing the spasticity, it is possible that the patients may at the same time The present study may serve as a basis for future clinical studies aiming at enhancing locomotor performance in sub-rely on this ''spasticity'' to some extent to maintain the tone and weight support ability. jects after injury to the CNS such as spinal cord injury or cerebrovascular accidents. Clinical studies using different Thus it is imperative to achieve a balance between reducing spasticity but maintaining the necessary muscle tone for pharmacological agents, such as clonidine and cyproheptadine (a serotonergic antagonist) were done in attempt to postural and locomotor function. The results in this study, showing differential effects mediated by a 1 -and a 2 -noraddecrease spasticity and/or improve locomotion in subjects with partial spinal cord injuries (Fung et al. 1990 ; Nance et renergic agonist, indicate that one way to achieve this balance may be through a combination of drugs. For example, al. 1985 For example, al. , 1994 Norman and Barbeau 1993; Wainberg et al. 1990) .
it is plausible that a combination of both a a 2 agonist (such as clonidine) and a a 1 agonist (methoxamine) may be beneThe reported therapeutic effects of clonidine, however, have been conflicting. Clonidine was found to reduce the ficial to patients with spinal cord injury. The effects of a a 1 agonist, which increased markedly the weight support abilspasticity but did not initiate or improve locomotion in patients with clinically complete spinal cord injury (Stewart et ity, combined with the effects of the a 2 agonists, which increased the cycle duration and step length, would likely al. 1991). In another study, clonidine was found to improve locomotion of subjects with more spasticity and functional produce the optimal locomotor effects in patients. The efficacy of such a therapeutic intervention awaits further investideficits but not in patients with less impaired locomotion (Norman and Barbeau 1993) . Another study using intrathe-gation in the clinical trials. Finally, the long-term effects exerted by single injections of oxymetazoline and methoxacal clonidine (15-90 mg) reported that although three of eight spinal cord-injured subjects showed an improvement in mine should not be overlooked as it also may present interesting therapeutic advantages. walking speed and reduced spasticity, the remaining patients showed no change or a deterioration of the locomotor pattern
In conclusion, the present study confirms that the descending noradrenergic system plays a crucial role in the initiation and sometimes a decrease in weight support abilities with higher dosage. . It was shown (Dietz and modulation of locomotion in chronic spinal cat. However, the fact that spinal animal can recover locomotion et al. 1995) that in two patients with complete paraplegia that although the overall locomotor pattern improved with suggests that the descending noradrenergic pathways are not 
